Research Progress of The Correlation between Lung Microbiome and Lung Cancer

Ming-jie NING; Ying CHEN

doi:10.12259/j.issn.2095-610X.S20210336

Volume 42 Issue 3

Apr. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2021 > 42(3): 155-160

Ming-jie NING, Ying CHEN. Research Progress of The Correlation between Lung Microbiome and Lung Cancer[J]. Journal of Kunming Medical University, 2021, 42(3): 155-160. doi: 10.12259/j.issn.2095-610X.S20210336

Citation:

Ming-jie NING, Ying CHEN. Research Progress of The Correlation between Lung Microbiome and Lung Cancer[J]. Journal of Kunming Medical University, 2021, 42(3): 155-160. doi: 10.12259/j.issn.2095-610X.S20210336

Citation:

PDF( 600 KB)

Research Progress of The Correlation between Lung Microbiome and Lung Cancer

doi: 10.12259/j.issn.2095-610X.S20210336

Ming-jie NING,
Ying CHEN^,

Dept. of Thoracic Surgery Ι，The Third Affiliated Hospital of Kunming Medical University，Yunnan Cancer Hospital，Yunnan Cancer Center，The International Cooperation Key Laboratory of Regional Tumor in High Altitude Area，Kunming Yunnan 650118，China

Received Date: 2020-12-16
Publish Date: 2021-03-25

Abstract

Abstract

Lung microbiome has become a hot topic in microbiome research field in recent years. Lung mircrobiota is different between healthy people and lung cancer patients. Environmental factors, smoking, genetic affect the lung microbiome and the development of lung cancer. Studies have found that the composition of the lower respiratory tract microorganisms of lung cancer patients is significantly different from that of healthy people. Therefore, improving lung microbiome to inhibit lung cancer, may promote the development of innovative strategies for early prevention and personalized treatment in lung cancer. This article reviewed the research on the corrrelation between lung microbiome between lung cancer.
- Lung microbiome,
- Lung cancer,
- Dysbiosis,
- Carcinogenesis

FullText(HTML)

References(49)

References

[1]	Nguyen L D N, Eric V, Laurence D. The lung mycobiome: An emerging field of the human respiratory microbiome[J]. Frontiers in Microbiology, 2015, 6: 89. DOI: 10.3389/fmicb.2015.00089
[2]	Liu H X,Tao L L,Zhang J,et al. Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects[J]. Int J Cancer,2018,142(4):769-778. doi: 10.1002/ijc.31098
[3]	Lee S H, Sung J Y, Yong D, et al. Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions[J]. Lung Cancer, 2016, 102: 89-95. DOI: 10.1016/j.lungcan.2016.10.016
[4]	Cameron S J S,Lewis K E,Huws S A,et al. A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer[J]. PLoS One,2017,12(5):e0177062. doi: 10.1371/journal.pone.0177062
[5]	Budden K F,Shukla S D,Rehman S F,et al. Functional effects of the microbiota in chronic respiratory disease[J]. Lancet Respir Med,2019,7(10):907-920. doi: 10.1016/S2213-2600(18)30510-1
[6]	Man W H,Wa D S P,Bogaert D. The microbiota of the respiratory tract:gatekeeper to respiratory health[J]. Nature Reviews Microbiology,2017,15(5):259. doi: 10.1038/nrmicro.2017.14
[7]	陈益民,沙建平,刘社兰,等. 肠道和呼吸道菌群与肺部疾病的研究新进展[J]. 中国微生态学杂志,2017,29(10):1234-1240.
[8]	Kelly B J,Imai I,Bittinger K,et al. Composition and dynamics of the respiratory tract microbiome in intubated patients[J]. Microbiome,2016,4(1):7. doi: 10.1186/s40168-016-0151-8
[9]	张鑫,马可,李赫,等. 呼吸道病毒和呼吸道、肠道菌群的相互作用[J]. 中国微生态学杂志,2017,29(1):109-112.
[10]	黄丹辉,何静,董航明,等. 肺部微生态与肺癌相关研究进展及展望[J]. 实用医学杂志,2019,35(11):1703-1707. doi: 10.3969/j.issn.1006-5725.2019.11.002
[11]	于文凯,徐星澈,袁晓鹏,等. 呼吸道菌群与呼吸系统疾病研究进展[J]. 重庆医学,2014,43(28):3802-3805. doi: 10.3969/j.issn.1671-8348.2014.28.040
[12]	Liu Y,O'Brien J L,Ajami N J,et al. Lung tissue microbial profile in lung cancer is distinct from emphysema[J]. Am J Cancer Res,2018,8(9):1775-1787.
[13]	Dickson R P,Erbdownward J R,Martinez F J,et al. The microbiome and the respiratory tract[J]. Annual Review of Physiology,2015,78(1):481.
[14]	Dickson R P,Erbdownward J R,Huffnagle G B. Homeostasis and its disruption in the lung microbiome[J]. American Journal of Physiology Lung Cellular & Molecular Physiology,2015,309(10):L1047.
[15]	Dickson R P,Erbdownward J R,Freeman C M,et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography[J]. Annals of the American Thoracic Society,2015,12(6):821. doi: 10.1513/AnnalsATS.201501-029OC
[16]	Chellappan D K, Sze Ning Q L, Su Min S K, et al. Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases [J]. Chem Biol Interact, 2019, 310: 108732. DOI: 10.1016/j.cbi.2019.108732
[17]	Venkataraman A, Bassis C M, Beck J M, et al. Application of a neutral community model to assess structuring of the human lung microbiome[J]. mBio, 2015, 6（1）: DOI: 10.1128/mBio.02284-14
[18]	Baquero F,Nombela C. The microbiome as a human organ[J]. Clinical Microbiology & Infection,2012,18(Suppl4):2.
[19]	李光剑. 燃煤中自然产出的二氧化硅与宣威地区农村女性肺癌的关系及致癌机制探索[D]. 昆明: 昆明医科大学博士学位论文, 2013.
[20]	Hosgood H D,3 rd,Sapkota A R,Rothman N,et al. The potential role of lung microbiota in lung cancer attributed to household coal burning exposures[J]. Environ Mol Mutagen,2014,55(8):643-651. doi: 10.1002/em.21878
[21]	Rylance J,Kankwatira A,Nelson D E,et al. Household air pollution and the lung microbiome of healthy adults in Malawi:a cross-sectional study[J]. BMC Microbiol,2016,16(1):182. doi: 10.1186/s12866-016-0803-7
[22]	Dave M,Ahankari A S,Myles P R,et al. Household air pollution and lung function in Indian adults:a cross-sectional study[J]. Int J Tuberc Lung Dis,2017,21(6):702-704. doi: 10.5588/ijtld.16.0615
[23]	Jary H R,Aston S,Ho A,et al. Household air pollution,chronic respiratory disease and pneumonia in Malawian adults:A case-control study[J]. Wellcome Open Res,2017,2:103. doi: 10.12688/wellcomeopenres.12621.1
[24]	Mutlu E A,Comba I Y,Cho T,et al. Inhalational exposure to particulate matter air pollution alters the composition of the gut microbiome[J]. Environmental Pollution,2018,240:817-830. doi: 10.1016/j.envpol.2018.04.130
[25]	肖纯凌,韩秀珍,魏德洲,等. 大气污染对人体免疫功能及微生态的影响[J]. 中国微生态学杂志,2002,14(1):12-13. doi: 10.3969/j.issn.1005-376X.2002.01.006
[26]	Jetté M E,Dill-Mcfarland K A,Hanshew A S,et al. The human laryngeal microbiome:effects of cigarette smoke and reflux[J]. Scientific Reports,2016,6:35882. doi: 10.1038/srep35882
[27]	Yang J,Mu X,Wang Y,et al. Dysbiosis of the salivary microbiome is associated with non-smoking female lung cancer and correlated with immunocytochemistry markers[J]. Frontiers in Oncology,2018,8:520. doi: 10.3389/fonc.2018.00520
[28]	Panzer A R,Lynch S V,Langelier C,et al. Lung microbiota is related to smoking status and to development of acute respiratory distress syndrome in critically ill trauma patients[J]. Am J Respir Crit Care Med,2018,197(5):621-631. doi: 10.1164/rccm.201702-0441OC
[29]	Kolde R,Franzosa E A,Rahnavard G,et al. Host genetic variation and its microbiome interactions within the Human Microbiome Project[J]. Genome Medicine,2018,10(1):6. doi: 10.1186/s13073-018-0515-8
[30]	Xie H,Guo R,Zhong H,et al. Shotgun metagenomics of 250 adult twins reveals genetic and environmental impacts on the gut microbiome[J]. Cell Systems,2016,3(6):572-584. doi: 10.1016/j.cels.2016.10.004
[31]	Hsiao J R,Chang C C,Lee W T,et al. The Interplay between oral microbiome,lifestyle factors,and genetic polymorphisms in the risk of oral squamous cell carcinoma[J]. Carcinogenesis,2018,39(6):778-787. doi: 10.1093/carcin/bgy053
[32]	Igartua C,Davenport E R,Gilad Y,et al. Host genetic variation in mucosal immunity pathways influences the upper airway microbiome[J]. Microbiome,2017,5(1):16. doi: 10.1186/s40168-016-0227-5
[33]	JK G,JL W,AC P,et al. Human genetics shape the gut microbiome[J]. Cell,2014,159(4):789-799. doi: 10.1016/j.cell.2014.09.053
[34]	Liotta L A,Kohn E C. The microenvironment of the tumour-host interface[J]. Nature,2001,411(6835):375-379. doi: 10.1038/35077241
[35]	Greathouse K L,White J R,Vargas A J,et al. Interaction between the microbiome and TP53 in human lung cancer[J]. Genome Biol,2018,19(1):123. doi: 10.1186/s13059-018-1501-6
[36]	Gomes S,Cavadas B,Ferreira J C,et al. Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma[J]. Sci Rep,2019,9(1):12838. doi: 10.1038/s41598-019-49195-w
[37]	Tsay J J,Wu B G,Badri M H,et al. Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer[J]. Am J Respir Crit Care Med,2018,198(9):1188-1198. doi: 10.1164/rccm.201710-2118OC
[38]	Chen J,Domingue J C,Sears C L. Microbiota dysbiosis in select human cancers:Evidence of association andcausality[J]. Seminars in Immunology,2017,32:25-34. doi: 10.1016/j.smim.2017.08.001
[39]	Cai Q,Long J,Xie H,et al. Abstract 3455:Association of oral microbiome with lung cancer risk:Results from the Southern Community Cohort Study[J]. Cancer Research,2016,76(14 Supplement):3455-3455.
[40]	余涛,俞万钧,王华英. PI3K/AKT信号通路在非小细胞肺癌中作用的研究进展[J]. 中国临床研究,2021,34(02):248-250+254.
[41]	Dickson R P,Erb-Downward J R,Falkowski N R,et al. The lung microbiota of healthy mice are highly variable,cluster by environment,and reflect variation in baseline lung innate immunity[J]. Am J Respir Crit Care Med,2018,198(4):497-508. doi: 10.1164/rccm.201711-2180OC
[42]	Dickson R P, Cox M J. The premature invocation of a ‘gut-lung axis’ may obscure the direct effects of respiratory microbiota on pneumonia susceptibility [J]. Gut, 2016, 66（2）: DOI: 10.1136/gutjnl-2016-311823
[43]	Adachi K,Tamada K. Microbial biomarkers for immune checkpoint blockade therapy against cancer[J]. J Gastroenterol,2018,53(9):999-1005. doi: 10.1007/s00535-018-1492-9
[44]	Kroemer G,Zitvogel L. Cancer immunotherapy in 2017:The breakthrough of the microbiota[J]. Nat Rev Immunol,2018,18(2):87-88. doi: 10.1038/nri.2018.4
[45]	Keen E C,Crofts T S,Dantas G. Checkpoint checkmate:Microbiota modulation of cancer immunotherapy[J]. Clin Chem,2018,64(9):1280-1283. doi: 10.1373/clinchem.2017.286229
[46]	Patel J,Crawford J M. Microbiota-regulated outcomes of human cancer immunotherapy via the PD-1/PD-L1 axis[J]. Biochemistry,2018,57(6):901-903. doi: 10.1021/acs.biochem.7b01249
[47]	Snyder A,Pamer E,Wolchok J. IMMUNOTHERAPY. Could microbial therapy boost cancer immunotherapy?[J]. Science,2015,350(6264):1031-1032. doi: 10.1126/science.aad7706
[48]	Vientós-Plotts A I,Ericsson A C,Rindt H,et al. Oral probiotics alter healthy feline respiratory microbiota[J]. Front Microbiol,2017,8:1287. doi: 10.3389/fmicb.2017.01287
[49]	Warusavitarne J,Stebbing J. Probiotics and cancer:ready for meal time?[J]. Lancet Oncology,2015,16(4):371-372. doi: 10.1016/S1470-2045(15)70149-X

Relative Articles(20)

Relative Articles

[1]	Ruicheng LI, Hongwei QIAN, Yanni FAN, Peipei ZHAO, Shan WEI, Huarong JING. Application of Logistic Regression and Artificial Neural Networks in the Differential Diagnosis of LC-MPE. Journal of Kunming Medical University, 2024, 45(10): 55-60. doi: 10.12259/j.issn.2095-610X.S20241009
[2]	Qun HUANG, Lili HOU, Degui WANG, Zhaojun WANG, Siyuan WU, Yingying SANG. The Effect of Active Circulatory Breathing Training in Patients undergoing Lung Cancer Surgery under 5A Mode. Journal of Kunming Medical University, 2024, 45(6): 190-196. doi: 10.12259/j.issn.2095-610X.S20240627
[3]	Hongbo ZHANG, Zhenlong LI, Ying LV, Yichao ZHANG, Xiangming QIU, Tingting HUANG. Comparison of Clinical Efficacy of Single-port and Double-port Video-assisted Thoracoscopic Lobectomy in the Treatment of Lung Cancer. Journal of Kunming Medical University, 2024, 45(4): 135-139. doi: 10.12259/j.issn.2095-610X.S20240419
[4]	Ying WANG, Cong FU, Ying FU. Clinical Implications of Serum LDH，CysC，and PWR Level Detection in Lung Cancer Patients. Journal of Kunming Medical University, 2024, 45(4): 163-169. doi: 10.12259/j.issn.2095-610X.S20240424
[5]	Jiang ZHANG, Xijuan ZHAO, Jiang WU, Bingkun YANG, Ni YANG, Liping ZHOU. Analysis of Frailty Status and Influencing Factors in Lung Cancer Patients Undergoing Radiotherapy. Journal of Kunming Medical University, 2024, 45(9): 1-8.
[6]	Yajie SAI, Lvxin YAO, Ling CHENG, Li SHEN, Cailian QI, Zhaoxia WANG, Huatao NIU. Correlation Analysis between the Caregiver Burden and Life Meaning in Patients with the Early Diagnosis of Lung Cancer. Journal of Kunming Medical University, 2023, 44(9): 171-175. doi: 10.12259/j.issn.2095-610X.S20230906
[7]	Qiao LUO, Hong SHI, Shaobo WANG. Role of α7-nicotinic Acetylcholine Receptor in Occurrence，Development and Therapy of Lung Cancer. Journal of Kunming Medical University, 2022, 43(2): 145-149. doi: 10.12259/j.issn.2095-610X.S20220226
[8]	Teng-fei ZHANG, Yue-feng HE, Lei ZHANG, Li ZHANG, Kai-yun YANG, Lian-qing LIU, Hui TAN. Expression of Long Non-coding RNA APTR，HEIH，FAS-ASA1，FAM83H-AS1，DICER1-AS1，PR-lncRNA in Lung Cancer. Journal of Kunming Medical University, 2021, 42(4): 49-52. doi: 10.12259/j.issn.2095-610X.S20210409
[9]	Jiang ZHANG, Xi-juan ZHAO, Jiang WU, Yan LIU, Li-juan LI, Ye CHEN. Application of Family Empowerment Nursing Intervention Program in Patients with Lung Cancer Undergoing Radiotherapy. Journal of Kunming Medical University, 2021, 42(12): 169-176. doi: 10.12259/j.issn.2095-610X.S20211242
[10]	Chang LIU, Zhen-hua LI, Ying WANG, Yan-qin RUAN, Lai-hao QU, Ding-biao LI. Applications of Lung Cancer MDT Combined with PBL + CBL Model in the Clinical Teaching. Journal of Kunming Medical University, 2021, 42(9): 162-166. doi: 10.12259/j.issn.2095-610X.S20210911
[11]	Li Meng Xian , Yu Jian Kun , Wen Yan Ping , Wu Han Xin , Gao Ling , Liu Xiao Xiao , Tai Wen Lin . . Journal of Kunming Medical University, 2020, 41(04): 51-55.
[12]	Zhao Min , Bi Jun Qiang , Zhou Yong Chun , Zhang Jin Ping , Luo Lei . Characteristics and Trends of Disease Constitution of 9553 Inpatients with Lung Cancer in Yunnan Province. Journal of Kunming Medical University, 2017, 38(04): 63-67.
[13]	Fan Min Juan , Zhong Yun Hua , Shen Wen , Yuan Kai Fen , Zhao Guo Hou , Wang Shu Kun , Wen Lin Qiao . HSF2 Promotes Heat Shock Protein Expression in Lung Cancer. Journal of Kunming Medical University, 2017, 38(06): 108-112.
[14]	Zhao Jie . The Expression and Significance of Galectin-3 in COPD and Lung Cancer. Journal of Kunming Medical University,
[15]	Wang Hong . Role of Prostaglandin E2 in the Pathogenesis of COPD with Lung Cancer. Journal of Kunming Medical University,
[16]	He Xiao Yu . . Journal of Kunming Medical University,
[17]	Pan Long Fang . . Journal of Kunming Medical University,
[18]	Ma Jian Qiang . . Journal of Kunming Medical University,
[19]	Chen Jin Run . . Journal of Kunming Medical University,
[20]	Chen Rui Bin . . Journal of Kunming Medical University,